Molecular Partners AG - American Depositary Shares - Çeyreklik Bilanço (NASDAQ:MOLN) | MetaTrader

Tam grafiği aç Full chart

Molecular Partners AG - American Depositary Shares

Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.

Haberler

Molecular Partners kanser ilacı MP0317 için Faz 1 verilerini açıkladı

H.C. Wainwright, Molecular Partners hissesi için al önerisini korudu

TD Cowen, Molecular Partners hissesi için hedef fiyatı korudu

TD Cowen reiterates Molecular Partners stock rating on radioligand platform potential

Will Petrobras Pull Off Q4 Earnings Beat on Strong Production?

Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript

H.C. Wainwright, Molecular Partners’a "Al" tavsiyesi ile takibe başladı

Molecular Partners stock initiated with Buy rating at H.C. Wainwright

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Intuitive Surgical (NASDAQ:ISRG), Mastercard (NYSE:MA)

Molecular Partners AG (MOLN) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:MOLN) 2026-01-19

Molecular Partners AG (MOLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - ECARX Holdings (NASDAQ:ECX), Daqo New Energy (NYSE:DQ)